EP1812032A4 - Gewebefaktorzusammensetzung und verfahren - Google Patents

Gewebefaktorzusammensetzung und verfahren

Info

Publication number
EP1812032A4
EP1812032A4 EP05825139A EP05825139A EP1812032A4 EP 1812032 A4 EP1812032 A4 EP 1812032A4 EP 05825139 A EP05825139 A EP 05825139A EP 05825139 A EP05825139 A EP 05825139A EP 1812032 A4 EP1812032 A4 EP 1812032A4
Authority
EP
European Patent Office
Prior art keywords
methods
tissue factor
factor composition
composition
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05825139A
Other languages
English (en)
French (fr)
Other versions
EP1812032A2 (de
Inventor
James H Morrissey
Vincent S Pureza
Stephen G Sligar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois at Urbana Champaign
University of Illinois System
Original Assignee
University of Illinois at Urbana Champaign
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois at Urbana Champaign, University of Illinois System filed Critical University of Illinois at Urbana Champaign
Publication of EP1812032A2 publication Critical patent/EP1812032A2/de
Publication of EP1812032A4 publication Critical patent/EP1812032A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP05825139A 2004-10-27 2005-10-27 Gewebefaktorzusammensetzung und verfahren Withdrawn EP1812032A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62273704P 2004-10-27 2004-10-27
PCT/US2005/038781 WO2006047684A2 (en) 2004-10-27 2005-10-27 Tissue factor phospholipid vesicle particles and methods of use for coagulation

Publications (2)

Publication Number Publication Date
EP1812032A2 EP1812032A2 (de) 2007-08-01
EP1812032A4 true EP1812032A4 (de) 2009-09-02

Family

ID=36228477

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05825139A Withdrawn EP1812032A4 (de) 2004-10-27 2005-10-27 Gewebefaktorzusammensetzung und verfahren

Country Status (2)

Country Link
EP (1) EP1812032A4 (de)
WO (1) WO2006047684A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140046277A1 (en) * 2011-04-15 2014-02-13 Gamma Therapeutics, Inc. Fast-clotting wound dressings
US20230338480A1 (en) * 2020-09-16 2023-10-26 Tissue-Link Aps A system to improve haemostatic control

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040501A2 (en) * 2000-11-20 2002-05-23 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US20040053384A1 (en) * 2000-11-20 2004-03-18 Sligar Stephen G. Membrane scaffold proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040501A2 (en) * 2000-11-20 2002-05-23 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US20040053384A1 (en) * 2000-11-20 2004-03-18 Sligar Stephen G. Membrane scaffold proteins

Also Published As

Publication number Publication date
WO2006047684A3 (en) 2006-07-27
EP1812032A2 (de) 2007-08-01
WO2006047684A2 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
GB0422525D0 (en) Dermatological compositions and methods
IL182734A0 (en) 4-aminotetracyclines and methods of use thereof
IL191072A0 (en) Therapeutic compositions and methods
ZA200701820B (en) Substituted phenylaminothiazoles and use thereof
IL184062A0 (en) Visco-supplement composition and methods
GB0416252D0 (en) Cosmetic method and composition
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
ZA200605722B (en) Composition and method
GB0520930D0 (en) Composition and method of use
ZA200706038B (en) Visco-supplement composition and methods
EP1812032A4 (de) Gewebefaktorzusammensetzung und verfahren
EP1810976A4 (de) Benzonaphthacenglykosidderivat und dessen verwendung
GB0403696D0 (en) Process and composition
GB0406014D0 (en) Pharmaceutical composition and use
GB0427723D0 (en) Compounds and their use
GB0428034D0 (en) Compositions and methods
GB0418363D0 (en) Therapeutic methods and compositions for use therein
GB0407993D0 (en) Therapeutic methods and compositions for use therein
GB0426756D0 (en) Composition and method
GB0411093D0 (en) Method and composition
GB0406949D0 (en) Composition and method
GB0417415D0 (en) Composition and method
GB0425737D0 (en) Composition and method
GB0517546D0 (en) Therapeutic methods and compositions
EP1841406A4 (de) Verfahren und formulierungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070523

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090730

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/00 20060101ALI20090724BHEP

Ipc: C07K 14/745 20060101ALI20090724BHEP

Ipc: A61K 9/127 20060101AFI20090724BHEP

Ipc: A61K 38/00 20060101ALI20090724BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091029